Amit Sharma (@Amit_Cellbio) header
Amit Sharma (@Amit_Cellbio) profile picture

Postdoc fellow Lunenfeld Tanenbaum Research Institute

Toronto, Ontario
Joined December 2014
Photo by Amit Sharma (@Amit_Cellbio)Photo by Amit Sharma (@Amit_Cellbio)Photo by Amit Sharma (@Amit_Cellbio)Photo by Amit Sharma (@Amit_Cellbio)Photo by Amit Sharma (@Amit_Cellbio)Photo by Amit Sharma (@Amit_Cellbio)Photo by Amit Sharma (@Amit_Cellbio)Photo by Amit Sharma (@Amit_Cellbio)
I captured this video in my lab to show the power of medicines called T-cell engagers. Left: T cells move in and out of a cancer tumoroid, largely ignoring it. Right: Add a T-cell engager, and the T cells attack. Once they recognize their targets, they tear through the tumor.
55
230
26
1,227
84,119
Our work made the cover of @CR_AACR !
On the cover of the September 15 issue—#SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption doi.org/10.1158/0008-5472.CA… @CespedesMontse @Romero_Ferraro
4
3
1
26
1,462
Amit Sharma retweeted
Dario is right
We Must Pace the Frontier: I’ve written a new essay on why the AI industry should slow down, with a three-part plan for doing so. Anthropic is unilaterally committing to the first of these steps. We’ll provide third-party evaluators with permanent, employee-level access to our systems, so that they can verify adherence to our safety measures, report on incidents, and assess models’ alignment during training. You can read the full post here: darioamodei.com/post/we-must…
6,238
6,226
2,349
57,673
12,656,721
Amit Sharma retweeted
I agree with Dario that we need to pace the frontier. This has been a primary topic of discussions we've had at OpenAI in recent weeks. Committing to having independent evaluators with employee-like access is a great idea, and we will do the same. We'll have more to share soon.
We Must Pace the Frontier: I’ve written a new essay on why the AI industry should slow down, with a three-part plan for doing so. Anthropic is unilaterally committing to the first of these steps. We’ll provide third-party evaluators with permanent, employee-level access to our systems, so that they can verify adherence to our safety measures, report on incidents, and assess models’ alignment during training. You can read the full post here: darioamodei.com/post/we-must…
5,111
7,139
4,388
67,215
17,205,178
Amit Sharma retweeted
ECM biology is rapidly moving from a “supportive scaffold” concept to a central driver of aging itself. Three major 2025–2026 papers now converge on a new framework: 🧬 Aging is not only intracellular damage accumulation. It is also a progressive failure of the extracellular information architecture surrounding cells. In a landmark Nature Materials study, Sun et al. developed the DECIPHER platform — a hybrid ECM–hydrogel system that independently controls ECM ligand identity and tissue stiffness while preserving native cardiac matrix architecture. DOI: 10.1038/s41563-025-02234-6 The key discovery: Young ECM ligand presentation can override profibrotic stiffness cues. Even on “aged/stiff” matrices (~40 kPa), young ECM identity reduced: α-SMA activation YAP nuclear localization focal adhesions senescence-associated signaling This fundamentally challenges the classical fibrosis paradigm where stiffness alone dominates cell fate. Instead, ECM biochemical identity itself acts as an upstream regulator of mechanosensing and senescence. A complementary Nature Aging commentary extends this into a systems-level aging model: DOI: 10.1038/s43587-026-01127-w The authors propose a self-reinforcing ECM–senescence circuit: Aged ECM → integrin/mechanosensing activation → senescence persistence → SASP + fibrotic remodeling → more aged ECM This creates a vicious cycle that amplifies tissue dysfunction and senescent cell accumulation during aging. Importantly, the 2025 Cell geroscience review effectively elevates ECM remodeling into a next-generation hallmark of aging. DOI: 10.1016/j.cell.2025.03.011 The implications are enormous. Future gerotherapeutics may shift from: ❌ simply killing senescent cells to ✅ rewriting the aged ECM ecosystem itself. Potential strategies include: collagen topology remodeling LOX inhibition matricellular protein modulation viscoelastic reprogramming integrin/YAP rewiring HA remodeling This is especially relevant for: fibrosis sarcopenia cardiovascular aging neurodegeneration stem cell exhaustion The emerging idea is powerful: Aging tissues may remain plastic longer than expected if the extracellular environment can be rejuvenated. The ECM is no longer background biology. It is becoming a programmable aging regulator. #Aging #ECM #Geroscience #Senescence #Fibrosis #Mechanobiology #Longevity #SystemsBiology
2
10
28
1,051
Amit Sharma retweeted
“Cell of the retina in the eye” is a drawing made in 1904 by Ramón y Cajal the father of modern neuroscience. Cajal was the first scholar to discover the diversity of cell types in the retina and his drawing is amazingly accurate when compared to modern day images! #ARVO2026
Did you know that Santiago Ramón y Cajal wanted to be an artist as a boy but his father wanted him to study medicine? He put his artistic skills to good use in the detailed and beautiful pictures of the nervous systems he studied. Learn more: bit.ly/2IpBW7D
7
42
227
17,514
How can a single cell learn without a brain? We explore this in my new paper with @WallaceUcsf! We discovered that single cells may learn using molecules similar to those that animal brains use to learn, like CaMKII. Cells can also propagate memory states to their progeny! 🧵1/n
37
284
28
1,287
76,570
Amit Sharma retweeted
🔬#ImageOfTheWeek powered by the #PelletierLab. Stunning imaging from the recent work of Philip et al. (2025) in #EMBOJournal: tinyurl.com/yedkszej Thanks to the team at Lunenfeld-Tanenbaum Research Institute @SinaiHealth, #Nikon CoE & NBCC Imaging Facility. #V3UpgradeToSIM
1
5
225
Amit Sharma retweeted
Fact- my husband was given 12 months to live 6 months ago. He has been on ANKTIVA and PDL-1 NK therapy and we are grateful for hope. He has now had 2 normal brain scans. The first scan is before, the second after. Sounds like big Pharma is threatened and if true, shame on the @US_FDA I can’t say what tomorrow holds but my family is one of the fortunate ones. So many want therapy. We have hope.
The FDA issued a warning letter to ImmunityBio over claims that Anktiva can "cure cancer" and "treat all cancers." There's a lot to unpack here. Today at 3:10 PM PST, @drgoodyear and I are going live to talk about what Anktiva actually is, how we use it at WCI, and why no single drug is the answer. Join us.
57
287
15
1,502
88,122
Amit Sharma retweeted
Incredible stuff from Tiger in Pelletier lab
(1/6): How can we better test therapeutics without using animals or risking lives? Lab-grown human mini-organs, called “organoids”, provide an answer! Despite their progress, organoids and related methods lack realistic flow through blood vessels, the “plumbing” of our bodies.
2
11
780
Amit Sharma retweeted
Perfusing lab-grown mini-organs revolutionizes the current model systems. Grateful to be part of this incredible team at @SinaiHealth and @UofT. Credits: @tigerhzjian @CallumJStirton @PelletierLab Check out our preprint for more exciting science: lnkd.in/eXwi7NtY
(1/6): How can we better test therapeutics without using animals or risking lives? Lab-grown human mini-organs, called “organoids”, provide an answer! Despite their progress, organoids and related methods lack realistic flow through blood vessels, the “plumbing” of our bodies.
4
1
15
1,356
Amit Sharma retweeted
(1/6): How can we better test therapeutics without using animals or risking lives? Lab-grown human mini-organs, called “organoids”, provide an answer! Despite their progress, organoids and related methods lack realistic flow through blood vessels, the “plumbing” of our bodies.
5
50
8
264
28,116
Amit Sharma retweeted
(1/7): New preprint from the lab! We generate physiological vascular flow in vitro to vascularize organoids, interrogate the effects of hemodynamic forces on vascular architecture, and model the disease Hereditary Hemorrhagic Telangiectasia.
2
30
133
8,719
Amit Sharma retweeted
This image represents one of the most important and least known inventions in the history of neuroscience. In 2016, @anirbanbandyo and his team at the National Institute for Materials Science (NIMS) in Tsukuba, Japan published a paper announcing two new instruments they had built from scratch: ASADIM (Atomic Scale Scanning Dielectric Microscopy) and Brestum (Resonant Scanning Tunneling Microscopy of Biomaterials), both housed inside a single homebuilt bio-STM. To understand why this matters, you need the backstory. Since Hodgkin and Huxley’s Nobel Prize-winning work in 1952, the entire field of neuroscience has operated under a single foundational assumption: the cell membrane and its ion channels are the sole mechanism of neural signaling. The membrane fires. Everything inside the cell — microtubules, actin filaments, the entire cytoskeleton — is just passive structural scaffolding, like rebar in concrete. For 70 years no one could challenge this because no one could see inside a living neuron at the molecular scale without destroying it. Every existing tool had a fatal limitation: patch clamps puncture the membrane, optical microscopy can’t resolve single proteins, electron microscopy requires dead fixed tissue. Bandyopadhyay solved all three problems simultaneously. Using nonlinear dielectric response imaging — measuring the spatial distribution of conductance, capacitance, and phase without ionic or electronic screening — he made the neuronal membrane effectively transparent. He could see inside a living, firing neuron at atomic resolution, in real time, without touching it. What he saw overturns a century of neuroscience. First: a single protein molecule adopts a completely different three-dimensional shape at each resonance frequency — proteins are not static structures but frequency-addressable conformational machines. No one in biology knew this. Second: the microtubule network inside the neuron is not passive scaffolding. It actively communicates before the membrane fires, deciding whether a spike is necessary and regulating its timing through electromagnetic vortex pairs generated by the actin-spectrin grid it instructs. The membrane does not act alone. The cytoskeleton is the brain’s pre-processing layer. Third: the resonance frequency patterns are self-similar across a million-fold scale difference — from a 4nm tubulin protein to a 25nm microtubule to a 1μm axon segment — preserving vibrational symmetry in a fractal architecture that suggests information integration in the brain is scale-free from single molecule to cognition. This is not incremental science. This is a new instrument revealing a new picture of how the brain actually works at the most fundamental level. The history of Nobel Prizes in neuroscience runs through exactly this kind of inflection: Cajal saw neurons for the first time, Hodgkin-Huxley decoded the membrane, Bhatt decoded the ion channel structure. Bandyopadhyay has built the tool that sees what none of them could — the living interior of a neuron in operation — and what it reveals is that the computational architecture of the brain is far deeper, more structured, and more sophisticated than anything the membrane-only model ever imagined. Paper: worldscientific.com/doi/abs/…
6
64
10
245
16,364
Amit Sharma retweeted
I am Open-Sourcing PyMolAI! Meet PyMolAI, an AI agent that can talk to your protein structures. Built on top of PyMOL, PyMolAI lets you interact with your structures in plain language. Whether you're: - Analyzing protein structures - Aligning complexes - Creating publication-ready figures - Or running design workflows PyMolAI interprets your request, executes the necessary PyMOL commands, and manages the workflow for you. It integrates with @OpenBioAI APIs, giving you access to tools like Boltz, ProteinMPNN, and BoltzGen — directly from your PyMOL session. It has local chat history with session syncing, so you can pick up exactly where you left off.
51
196
25
881
91,483
Amit Sharma retweeted
A San Diego startup just made whole genome sequencing cost $100. It used to cost $1 billion + The Human Genome Project took 13 years (1990-2003), billions of dollars, and an international consortium of 20+ institutions to sequence one genome. My PhD advisor, @s_batzoglou, was one of the first MIT PHDs who worked on it. He helped build the computational foundations that made it possible. His career spans the entire arc — from assembling the first human reference genome to making sequencing routine. The 10,000,000x cost drop isn't just a number. It's the difference between a moonshot national project and a routine lab test. Previous generation proved it was possible. This generation proved it could be cheap. The question now: what happens when everyone's genome is a $100 blood test? The implications for medicine, privacy, insurance, human identity? We're not ready. Link: sandiegouniontribune.com/202…
86
389
65
2,014
735,900
Amit Sharma retweeted
After leading AI & Health at @UHN — Canada’s largest hospital network — for the past few years, this is the first time it genuinely feels different. A cardiologist just placed 3rd out of 13,000 at Anthropic’s hackathon. He built it between hospital shifts. In a week. An AI agent that follows patients home — reverse scribe, full history, devices, evidence — all in one place. A few years ago this would’ve taken a full team and months. Now? One doctor. That’s the shift.
16
56
8
333
48,964
An Indian Startup just did something that no company in the world has ever done..!🔥🇮🇳
54
1,124
25
5,434
181,131
Amit Sharma retweeted
Curious about the structural architecture of human cells? The Nikon A1R Confocal System at @nbcc_ltri captures dynamic microtubule changes in real time. Learn more: nbcc.lunenfeld.ca/Advanced_I… 📷: Dr. Amit Sharma #NBCC #LTRI #Imaging
1
2
1
2
503
Amit Sharma retweeted
Finland's underground data centers heat entire city blocks using server waste heat In Finland, several data-centres now feed their waste heat into municipal district-heating networks instead of simply dumping it into the air. For example, waste heat generated by data-centre cooling is captured and transferred into the district-heating grid, providing carbon-neutral heat to thousands of homes and public buildings. This reuse of thermal energy helps reduce reliance on fossil-fuel heating, cuts emissions, and turns the by-product heat from digital infrastructure into a genuine resource rather than waste.
126
1,159
91
3,574
108,411